logo
episode-header-image
Jan 2024
16m 20s

Is this nuclear power’s moment?

Financial Times
About this episode

The nuclear power industry is receiving a lot of attention recently thanks in part to new technological advancements. That’s excited venture capital groups and private investors, such as Bill Gates and OpenAI’s Sam Altman. But the industry is also known for its boom-and-bust cycles. The FT’s US energy editor Jamie Smyth explains there are many challenges that lie ahead for an industry, which has long been plagued by controversy.   

- - - - - - - - - - - - - - - - - - - - - - - - - - 

For further reading:

The US plan to break Russia’s grip on nuclear fuel

US nuclear start-ups battle funding challenge in race to curb emissions

Nuclear fission start-up backed by Sam Altman to go public

- - - - - - - - - - - - - - - - - - - - - - - - - - 

On X, follow Jamie Smyth (@JamieSmythF) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more.


Read a transcript of this episode on FT.com



Hosted on Acast. See acast.com/privacy for more information.

Up next
Yesterday
Coming soon from Tech Tonic: Defying death
<p>Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing efforts have moved from the super rich to a mass market consumer industry. I ... Show More
1m 30s
Nov 19
What’s the deal with OpenAI's deals?
<p>OpenAI is entering a new era. It's restructured to add a for-profit arm to its business and has signed more than a trillion dollars’ worth of deals to secure chips and build out data centres. But those huge financial commitments also raise massive questions: How will a heavily ... Show More
26m 5s
Nov 12
Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs
Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multibillion-dollar battle for control of biotech start-up Metsera. The FT’s US deals ... Show More
26m 3s
Recommended Episodes
Mar 2024
A Nuclear Comeback: Are New Reactors the Answer?
<p>Nuclear energy accounts for 20% of the electricity in the United States, but remarkably, 2023 marked the commissioning of the U.S.'s first new nuclear reactor in over three decades. The past few years have been a story of changing public opinion, but equally, innovative startu ... Show More
47m 51s
Jan 2023
The Renaissance of Nuclear Power
<p><strong>What’s led the world to restart the stalled atomic engine?</strong></p><p><br></p><p>2022 was a year of important milestones for nuclear power. The most significant piece of climate legislation in US history – the IRA – included tax incentives and investment for the nu ... Show More
54m 29s
Jan 2022
The future of hydrogen and nuclear on the path to net zero
<p>With Abu Dhabi Sustainability Week and the World Future Energy Summit under way in the UAE, the path to net zero is becoming clearer with an energy mix of hydrogen, nuclear and renewables alongside innovations such as carbon capture and battery storage.</p> <p>Co-hosts Mustafa ... Show More
17m 43s
Mar 2022
Des mini-réacteur nucléaire pour verdir l'industrie ?
<p>Et si le secteur industriel pouvait se décarbonner grâce à des mini-réacteur nucléaires ? C'est en tout cas ce que pense Jimmy, startup française spécialisée dans cette technologie. En quoi le nucléaire pourrait permettre d'éviter les gaz à effet de serre émis par l'industrie ... Show More
2m 1s
Oct 2020
The nuclear industry dreams small
Could the future of nuclear power be the mass production of cheap small modular reactors?Justin Rowlatt visits a UK-based consortium led by Rolls Royce that is trying to develop these factory-produced miniature power stations. But how much funding does their chief executive Tom S ... Show More
19m 28s